Alpa Laboratories Limited has submitted comprehensive disclosures to stock exchanges regarding a share transfer transaction between promoter group members under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The transaction involved the transfer of 21,940 equity shares as a gift between immediate relatives of the promoter group on March 7, 2026.

Transaction Overview

The share transfer involved Mr. Vinit Shah acquiring equity shares from Bakulesh Chandulal Shah HUF through an off-market inter se transfer by way of gift. The transaction details are summarized below:

Shareholding Changes

The transaction resulted in a complete transfer of shareholding between the two parties, with no net change in promoter group holdings:

Regulatory Compliance Framework

The company has filed comprehensive disclosures with both National Stock Exchange of India Limited and Bombay Stock Exchange Limited under multiple regulations:

The transaction is exempt from open offer requirements under Regulation 10(1)(a)(i) of SEBI (SAST) Regulations, 2011, as it involves transfer between immediate relatives of promoter group members. Both parties have confirmed their status as part of the promoter/promoter group of Alpa Laboratories Limited.

Company Statement and Compliance

Alpa Laboratories Limited has confirmed through Company Secretary Prashiti Chopra that there is no change in the total shareholding of promoter and promoter group of the company pre and post transfer of shares. The company has requested stock exchanges to update their records with the disclosed information for compliance purposes.

All disclosures were signed and dated March 7, 2026, from Indore, with Mr. Vinit Shah signing as the acquirer and Bakulesh Shah signing as Karta of Bakulesh Chandulal Shah HUF for the disposal transaction. The company maintains its equity share capital at 21,040,600 shares with no dilution effect from this inter se transfer.

Alpa Laboratories Limited has announced a key management change with the resignation of its Company Secretary and Compliance Officer. The pharmaceutical company, based in Indore, Madhya Pradesh, has informed stock exchanges about this corporate development in accordance with regulatory requirements.

Key Management Change Details

Ms. Srashiti Chopra has tendered her resignation from the position of Company Secretary and Compliance Officer of Alpa Laboratories Limited. The resignation letter was submitted on February 25, 2026, with the cessation taking effect from the close of business hours on March 25, 2026.

Regulatory Compliance and Notification

The company has fulfilled its disclosure obligations under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Formal notifications were sent to both major stock exchanges where the company's shares are listed.

The regulatory filings were addressed to:

• National Stock Exchange of India Limited (Scrip Code: ALPA)
• Bombay Stock Exchange Limited (Scrip Code: 532878)

Transition and Professional Acknowledgment

In her resignation letter, Ms. Chopra expressed appreciation for the opportunities and professional experience gained during her tenure with the organization. She acknowledged the guidance, support, and trust extended to her throughout her association with the company.

Key aspects of the transition include:

• Commitment to ensuring smooth handover of responsibilities
• Completion of all pending assignments during the notice period
• Close collaboration with the team to maintain work continuity
• Full dedication to duties until the effective resignation date

Corporate Governance Impact

The resignation represents a significant change in the company's compliance and secretarial functions. As Company Secretary and Compliance Officer, Ms. Chopra was responsible for ensuring adherence to regulatory requirements and maintaining corporate governance standards. The company will need to identify and appoint a suitable replacement to fill this critical role.

Director Mahendra Singh Chawla signed the official communication to the stock exchanges, confirming the company's commitment to transparent disclosure of material changes in key management personnel.